Cite
HARVARD Citation
Manasson, J. et al. (2020). Interleukin‐17 Inhibition in Spondyloarthritis Is Associated With Subclinical Gut Microbiome Perturbations and a Distinctive Interleukin‐25–Driven Intestinal Inflammation. Arthritis & rheumatology. 72 (4), pp. 645-657. [Online].